Menu
Fechar
hrs4r
Quiero donar

ESTER QUINTANA CAMPS

Neurodegeneració i Neuroinflamació
Personal de plataformas científicas
Firma
ESTER QUINTANA-CAMPS
Posición
Coordinadora de laboratorios
Investigadores/as Post-doctorales – R2
Projectes
Publicacions

Projectes

Neurodegenerativas y neuroinflamación

Red Española de Esclerosis Múltiple

Codi oficial: RD16/0015/0006 Data inicio:01/01/2017 Data fi: 31/12/2021 Investigador/a principal: LLUÍS RAMIÓ I TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 5,500 €
Neurodegenerativas y neuroinflamación

Proyectos Bianuales EME-REEM 2020

Codi oficial: EME-REEM 2020 Data inicio:01/07/2020 Data fi: 31/03/2023 Investigador/a principal: LLUÍS RAMIÓ TORRENTÀ Organisme finançador: ASOC. ESCLEROSIS MULTIPLE ESPAÑA Ajuda: 40,000 €

Publicacions

Muñoz-San Martín M, Gómez I, Quiroga-Varela A, Gonzalez-Del Río M, Robles Cedeño R, Álvarez G, Buxó M, Miguela A, Villar LM, Castillo-Villalba J, Casanova B, Quintana E, Ramió-Torrentà L

miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 dx.doi.org/10.1212/NXI.0000000000200069
Coll-Martinez C, Salavedra-Pont J, Buxó M, Quintana E, Quiroga-Varela A, Robles-Cedeño R, Puig M, Álvarez-Bravo G, Ramió-Torrentà L, Gich J

Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors.

Frontiers in Psychology, 2023, 14, 1163112-1163112 dx.doi.org/10.3389/fpsyg.2023.1163112
Coll-Martinez C, Quintana E, Buxó M, Salavedra-Pont J, Gasull-Vicens L, Quiroga-Varela A, Costa-Frossard L, Villar LM, Fernández-Díaz E, Gracia J, Aladro Y, Méndez-Burgos A, Cerezo M, Ramió-Torrentà L, Gich J

Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68, 104397-104397 dx.doi.org/10.1016/j.msard.2022.104397
Muñoz-San Martín M, Gomez I, Miguela A, Belchí O, Robles-Cedeño R, Quintana E, Ramió-Torrentà L

Description of a CSF-Enriched miRNA Panel for the Study of Neurological Diseases

LIFE-BASEL, 2021, 11 dx.doi.org/10.3390/life11070594
Picón C, Tejeda-Velarde A, Fernández-Velasco JI, Comabella M, Álvarez-Lafuente R, Quintana E, Sainz de la Maza S, Monreal E, Villarrubia N, Álvarez-Cermeño JC, Domínguez-Mozo MI, Ramió-Torrentà L, Rodríguez-Martín E, Roldán E, Aladro Y, Medina S, Espiño M, Masjuan J, Matute-Blanch C, Muñoz-San Martín M, Espejo C, Guaza C, Muriel A, Costa-Frossard L, Villar LM

Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis

Frontiers in Immunology, 2021, 12, 685139-685139 dx.doi.org/10.3389/fimmu.2021.685139
Coll-Martinez C, Quintana E, Salavedra-Pont J, Buxó M, González-Del-Rio M, Gómez I, Muñoz-San Martín M, Villar LM, Álvarez-Bravo G, Robles-Cedeño R, Ramió-Torrentà L, Gich J

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

BRAIN AND BEHAVIOR, 2021, 11 dx.doi.org/10.1002/brb3.2405
Walo-Delgado PE, Monreal E, Medina S, Quintana E, Sainz de la Maza S, Fernández-Velasco JI, Lapuente P, Comabella M, Ramió-Torrentà L, Montalban X, Midaglia L, Villarrubia N, Carrasco-Sayalero A, Rodríguez-Martín E, Roldán E, Meca-Lallana J, Alvarez-Lafuente R, Masjuan J, Costa-Frossard L, Villar LM

Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab

Frontiers in Immunology, 2021, 12, 760546-760546 dx.doi.org/10.3389/fimmu.2021.760546
Aliaga-Gaspar P, Hurtado-Guerrero I, Ciano-Petersen NL, Urbaneja P, Brichette-Mieg I, Reyes V, Rodriguez-Bada JL, Alvarez-Lafuente R, Arroyo R, Quintana E, Ramió-Torrentà L, Alonso A, Leyva L, Fernández O, Oliver-Martos B

Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment

Frontiers in Immunology, 2021, 12, 778204-778204 dx.doi.org/10.3389/fimmu.2021.778204
Tomas-Roig J, Agbemenyah HY, Celarain N, Quintana E, Ramió-Torrentà L, Havemann-Reinecke U

Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insult

SCIENTIFIC REPORTS, 2020, 10, 590-590 dx.doi.org/10.1038/s41598-019-57290-1
Gil-Varea E, Spataro N, Villar LM, Tejeda-Velarde A, Midaglia L, Matesanz F, Malhotra S, Eixarch H, Patsopoulos N, Fernández Ó, Oliver-Martos B, Saiz A, Llufriu S, Ramió-Torrentà L, Quintana E, Izquierdo G, Alcina A, Bosch E, Navarro A, Montalban X, Comabella M

Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes

HUMAN MUTATION, 2020, 41, 1308-1320 dx.doi.org/10.1002/humu.24016

Formulari de contacte

Conoce el IDIBGI!

 menu